Class II
Terminated
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd.
Why: Failed Dissolution Specifications
- Company
- Zydus Pharmaceuticals (USA) Inc
Pennington, NJ, United States - Reported
- Dec 23, 2020
- Recall started
- Dec 3, 2020
- Ended
- Dec 20, 2022
- Where sold
- Nationwide
- Amount
- 22,848 cartons
- Full product description
- Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 NDC 68382-772-77
- Lots / codes affected
- M900412 December 2020 M904772 February 2021 M915745 October 2021
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.